Congenital cytomegalovirus (CMV) infections: Hats off to Alabama

Journal of Pediatrics

Volumn 143, Issue 1, 2003, Pages 4-6

  Prober, Charles G ^a   Enright, Andrea M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS VACCINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; VALGANCICLOVIR;

CARCINOGENICITY; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOUBLE BLIND PROCEDURE; EDITORIAL; EVOKED BRAIN STEM RESPONSE; GONADAL DISEASE; HEALTH CARE COST; HEARING; HUMAN; INCIDENCE; INFANT; NEUROLOGIC DISEASE; NEUTROPENIA; NEWBORN; PERCEPTION DEAFNESS; PHASE 3 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; SYMPTOMATOLOGY; UNITED STATES; VIRUS TRANSMISSION;

EID: 0043245883     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(03)00290-7     Document Type: Article

References (25)

1. Prober CG. Introduction to Herpesviridae. In: Long SS, Pickering LP, Prober CG, eds. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingstone; 2003. P. 1031-2.
2. Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980;66:758-62.
3. Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 1999;135:60-4.
4. Pass RF. Viral infections in the fetus and newborn. In: Long SS, Pickering LP, Prober CG, eds. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingstone; 2003. P. 543-6.
5. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RI, Walton PD, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904-8.
6. Pass RF. Cytomegalovirus. In: Long SS, Pickering LP, Prober CG, eds. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingstone; 2003. P. 1050-8.
7. Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA Jr. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973;289:1-5.
8. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999;104:55-60.
9. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptual immunity. N Engl J Med 2001;344:1366-71.
10. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003;289:1008-11.
11. Demmler GJ. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-29.
12. Yow MD, Demmler GJ. Congenital cytomegalovirus disease-20 years is long enough. N Engl J Med 1992;326:702-3.
13. The Jordan Report 2000: Accelerated Development of Diseases. National Institutes of Health: National Institute of Allergy and Infectious Diseases; 2000.
14. Adler SP, Stuart ES, Plotkin SA, Hempfling SH, Buis J, Manning ML, et al. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 1995;171:26-32.
15. Britt WJ, Vugler L, Stephens EB. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J Virol 1998;62:3309-18.
16. Pass RF, Duliege AM, Boppana S, Sekulovich R, Percell S, Britt W, et al. Subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and new adjuvant. J Infect Dis 1999;180:970-5.
17. Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 2002;110:762-7.
18. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997;130:624-30.
19. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 1990;12(Suppl 7):S745-53.
20. Trang JM, Kidd L, Gruber W, Storch G, Demmler G, Jacobs R, et al, and the NIAID Collaborative Antiviral Study Group. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clin Pharmacol Ther 1993;53:15-21.
21. Zhou XJ, Gruber W, Demmler G, Jacobs R, Reuman P, Adler S, et al, and the NIAID Collaborative Antlviral Study Group. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovlrus infections. Antimicrob Agents Chemother 1996;40:2202-5.
22. Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, et al, and the NIAID Collaborative Antiviral Study Group. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J Infect Dis 1997;175:1080-6.
23. Kimberlin DW, Lin C-Y, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al, and the NIAID Collaborative Antiviral Study Group. Effect of ganciclovir therapy on heating in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143:17-26.
24. Red Book 2003. Report on the Committee on Infectious Diseases, 26th Edition. Pinckering LP, ed. American Academy of Pediatrics; 2003.
25. Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, et al, and the Valganciclovir Study Group. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002;346:1119-26.